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Abstract
Fullerene C60 as a representative of carbon nanocompounds is suggested to be promising agent for application
in photodynamic therapy due to its unique physicochemical properties. The goal of this study was to estimate the
accumulation of fullerene C60 in leukemic cells and to investigate its phototoxic effect on parental and resistant to
cisplatin leukemic cells. Stable homogeneous water colloid solution of pristine C60 with average 50-nm diameter
of nanoparticles was used in experiments. Fluorescent labeled C60 was synthesized by covalent conjugation of C60
with rhodamine B isothiocyanate. The results of confocal microscopy showed that leukemic Jurkat cells could
effectively uptake fullerene C60 from the medium. Light-emitting diode lamp (100 mW cm
−2, λ = 420–700 nm)
was used for excitation of accumulated C60. A time-dependent decrease of viability was detected when leukemic
Jurkat cells were exposed to combined treatment with C60 and visible light. The cytotoxic effect of photoexcited
C60 was comparable with that induced by H2O2, as both agents caused 50% decrease of cell viability at 24 h at
concentrations about 50 μM. Using immunoblot analysis, protein phosphotyrosine levels in cells were estimated.
Combined action of C60 and visible light was followed by decrease of cellular proteins phosphorylation on tyrosine
residues though less intensive as compared with that induced by H2O2 or protein tyrosine kinase inhibitor
staurosporine. All tested agents reduced phosphorylation of 55, 70, and 90 kDa proteins while total suppression
of 26 kDa protein phosphorylation was specific only for photoexcited C60.
The cytotoxic effect of C60 in combination with visible light irradiation was demonstrated also on leukemic
L1210 cells both sensitive and resistant to cisplatin. It was shown that relative value of mitochondrial membrane
potential measured with tetramethylrhodamine ethyl ester perchlorate (TMRE) probe was lower in resistant cells
in comparison with sensitive cells and the drop of mitochondrial potential corresponded to further decrease
of resistant cell viability after C60 photoexcitation. The data obtained allow to suggest that C60-mediated
photodynamic treatment is a candidate for restoration of drug-resistant leukemic cell sensitivity to induction
of mitochondrial way of apoptosis.
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Background
Fullerene C60 as a representative of a new structurally
distinguished class of carbon nanocompounds is of inter-
est for biomedical application. Its symmetrical molecule
consists of 60 carbon atoms connected by sp2 bonds and
arranged in a structure with condensed aromatic rings.
The extended electron π-conjugation system determines
the dual property of C60. High affinity of fullerene core for
electron donors determines its ability to be a scavenger of
free radicals. On the other hand, C60 molecule is able to
absorb effectively UV and visible light with further transi-
tion to the first singlet excited state, then to a long-lived
triplet excited state and subsequent energy transfer to mo-
lecular oxygen-yielding singlet oxygen with quantum yield
close to 100% [1, 2]. Illumination of C60 in cell environ-
ment containing reducing agents is followed by electron
transfer from fullerene triplet to molecular oxygen form-
ing highly reactive cytotoxic superoxide and hydroxyl
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radicals. These unique photochemical properties of C60
are of particular interest for application as a photosensi-
tizer to photodynamic therapy (PDT) of cancer. Cancer
cells are metabolically active and produce high levels of re-
active oxygen species (ROS); however, additional oxidative
stress by exogenous ROS would result in irreversible cell
damage and induction of apoptosis [3, 4].
C60 advantages in comparison with traditionally used
photosensitizers are high absorption coefficients, high de-
gree of photostability, little photobleaching, and prolonged
response to irradiation due to the presence of multiple
aromatic bonds, which are able to resist a certain interrup-
tion of π-conjugation caused by ROS back attack [5, 6].
The disadvantages of C60 bioapplication are its poor
solubility in polar medium and heterogeneity of its ag-
gregates in water solutions. A lot of efforts were done to
improve its water solubility, including covalent modifica-
tion with polar substituents and complex formation with
hydrophilic polymers [7–9]. However, functionalization
of fullerene molecule could be followed by decrease of
photoactivation efficacy for several reasons: covalent
modification of C60 core has been shown to change car-
bon atoms sp2 hybridization to the less-strained sp3 state
[10]; branches of substituent could keep C60 structure
far from the cell membrane and ROS produced could be
inactivated before reaching the membrane [11]; in order
to attain substantial content of C60 in complexes, the con-
centration of polymeric carrier must be high [12]; applica-
tion of some polymeric micelles as carrier systems could
be associated with toxic effects [13].
Nevertheless, employment of pristine C60 and its
derivatives as photosensitizers in PDT have been shown
to induce oxidative damage of membrane lipids, cleav-
age of DNA strands, and killing of cancer cells (HeLa
and hepatoma cells) both in vitro [14] and in vivo in
mouse abdominal and murine subcutaneous tumor
models [5, 15]. It should be noted that in a number of
works, pristine nonexcited fullerene C60 in concentra-
tions up to 10−5–10−4 M was shown to be nontoxic in
normal cells [12, 16, 17].
ROS attack initiated by photoexcited C60 is directed
on multiple cellular targets both in membranes due to
C60 high lipophilicity and in intracellular space due to
C60 ability to penetrate plasma membrane. However, a
number of issues concerning C60 accumulation by can-
cer cells of different types and biochemical mechanisms
of its photocytotoxic effects remain still open.
Considering the fact that multidrug resistance of can-
cer cells significantly limits the efficiency of anticancer
therapy, new therapeutic strategies with the use of C60
derivatives are developing now [18, 19]. At the same
time, the cytotoxic potential of C60 in photodynamic
therapy on drug-resistant cancer cells requires further
elucidation.
The goal of this study was to estimate accumulation of
fullerene C60 in leukemic cells and to investigate its pho-




Staurosporine (STS), hydrogen peroxide (H2O2), MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide), rhodamine B isothiocyanate (RITC), tetra-
methylrhodamine ethyl ester perchlorate (TMRE), anti-
bodies against β-actin (1:2000 dilution), cisplatin (cis-Pt,
Sigma-Aldrich Co, Ltd, USA), monoclonal antibodies
against phosphotyrosine (Upstate Biotechnology Inc.,
USA), pyridine (Merck), and trifluoromethanesulfonic acid
(Alfa Aesar) were used.
Characterization of C60 Water Colloid Solution
The toluene extract obtained after graphite combustion
was fractionated by gas-liquid chromatography. After tolu-
ene evaporation, fullerene C60 was transferred to water
phase followed by prolonged ultrasound sonication
(8 Hz, 8 h). Dark brown water solution of fullerene C60
(concentration 10−4 M, purity 99.5%) is highly stable
(12–18 months when stored at +4 °C) molecular-colloidal
system which does not contain stabilizers [20].
Using laser correlation spectroscopy, we have showed
that the hydrodynamic diameter of fullerene C60 nano-
particles ranged from 12 to 72 nm with the mean peak
position at 50 nm. No changes of fullerene C60 clusters
diameter were detected in RPMI-1640 medium contain-
ing 5% fetal bovine serum (FBS) [21].
Cellular Uptake of Fullerene C60
To study the fullerene C60 intracellular localization in
leukemic cells, the fluorescent-labeled fullerene C60,
synthesized by covalent conjugation of C60 with rhoda-
mine B isothiocyanate, was used. The precursor N-tri-
phenylmethyl pyrrolidine-C60 was synthesized following
the general strategy for the synthesis of fulleropyrroli-
dines [22, 23]. Exposure of trityl-fulleropyrrolidine to
trifluoromethanesulfonic acid followed by addition of
pyridine and rhodamine B isothiocyanate was accompan-
ied by the attack of the carbon atom of isothiocyanate
functional group by the amino group of fulleropyrrolidine
giving a thiourea funtionality. Stirring in the dark at room
temperature for 6 days was followed by formation of the
product N-rhodamine-B-5-isothiocyanate pyrrolidine-C60
(C60-RITC) (Fig. 1).
The precipitate was washed with dichloromethane to
remove any excess of RITC and dried. Ethanol water
(1:2) suspension of C60-RITC was prepared by ultrasoni-
cation of sample for 2 min and further precipitation of
insoluble moiety of the compound. The hydrolysis of the
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compound was slow, and suspension was stable for ap-
proximately 1 month when kept in the dark.
Leukemic cells were treated with C60-RITC for 2 and
18 h, washed from excess of label and fixed preparations
were obtained. Intracellular content of C60-RITC was de-
tected with a confocal microscope Carl Zeiss LSM 510
(Germany). Argon laser (λ = 543 nm) was used for RITC
excitation. The intensity of fluorescence was estimated
with the use of Zeiss LSM Image Brouser program.
Cell Culture and Photodynamic Treatment
Leukemic cells of Jurkat and L1210 lines were obtained
from the Bank of Cell Lines from Human and Animal
Tissues, R. E. Kavetsky Institute of Experimental Path-
ology, Oncology and Radiobiology, NAS of Ukraine
(Kyiv, Ukraine).
Cells were cultured in RPMI-1640 medium supple-
mented with 10% FBS (Sigma-Aldrich, Germany),
50 μg ml−1 penicillin, and 100 μg ml−1 streptomycin at
37 °C in a humidified atmosphere with 5% CO2. Cells were
incubated for 2 h with or without fullerene C60. Photoacti-
vation of accumulated fullerene C60 was done by probe
irradiation in microplates with light-emitting diode lamp
(LED) (420–70 nm light, irradiance 100 mW cm−2).
Cell Viability (MTT) Assay
Cell viability was assessed by MTT reduction assay [24].
At indicated time points of incubation, 200 μl aliquots
were removed from cell suspensions into the 96-well
microplates (1 × 105/well), 20 μl of MTT solution
(2,5 μg ml−1) was added, and the plates were incubated for
another 2 h. The culture medium was then replaced with
100 μl of DMSO. Diformazan formation was determined
by measuring absorption at 570 nm with a plate reader
(μQuant, BioTek, USA).
Immunoblot Analysis
Immunoblotting was performed as described in [25]. Cells
were washed with PBS and lysed with ice-cold lysis buffer
containing complete protease inhibitor cocktail tablet. Cell
lysates were clarified by centrifugation (14.000g, 15 min).
About 30 μg of cell lysate, total protein was loaded onto a
gradient 8–15% SDS-polyacrylamide gel. After electro-
phoresis, the proteins were transferred onto PVDF
membrane and incubated with monoclonal antibody
against phosphotyrosine at a dilution of 1:1000 overnight
at 4 °C. The membranes were washed and incubated with
goat anti-mouse peroxidase-linked secondary antibody for
1 h. Immunoreactive bands were visualized by enhanced
chemiluminescence with an ECL plus Western blotting
detection system (Amersham, USA). The same mem-
branes were incubated with antibodies against β-actin
(Sigma, USA, 1:2000 dilution) to provide an internal load-
ing control.
Mitochondrial Transmembrane Potential Aassay
Mitochondrial membrane potential was determined with
fluorescent potential-sensitive probe TMRE. Cells
(107 ml−1) suspended in buffer. A consisting of (mM):
KCl—5, NaCl—120, CaCl2—1, glucose—10, MgCl2—1,
NaHCO3—4, HEPES—10, pH 7.4 were incubated with
100 nM TMRE for 40 min at 25 °C with addition of
0.05% Pluronic F-127, washed from excess of probe, and
further incubated for different time points. TMRE
fluorescence was registered with Shimadzu RF-1501
spectrofluorometer (Japan), λexc = 540 nm, λem =
595 nm. Relative values of mitochondrial potential were
determined as changes in probe fluorescence after
addition of protonophore FCCP (1 μM) [26].
Statistical Analysis
The data were represented as mean ± SD of more than
four independent experiments. Mean (M) and standard
deviation (SD) were calculated for each group. Statistical
analysis was performed using two-way ANOVA followed
by post Bonferroni tests. A value of p < 0.05 was consid-
ered statistically significant. Data processing and plotting
were performed by IBM PC using specialized applications
GraphPad Prism 7 (GraphPad Software Inc., USA) and
Gel-Pro Analyzer 6.3 (Media Cybernetics Inc., USA).
Results and Discussion
High lipophilicity of fullerene C60 molecule determines
its affinity to membrane lipid bilayer and ability to
Fig. 1 Structure of C60-RITC
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penetrate cell plasma membrane. It is suggested that
interaction of C60 cluster with membrane is followed by
disaggregation of nC60 within bilayer and diffusion of
molecules through transient micropores [27]. To esti-
mate the uptake of C60 by leukemic cells, we used the
fluorescent-labeled C60 obtained by covalent conjugation
of C60 with rhodamine B isothiocyanate (C60-RITC). The
conjugate was proved to be a nice fluorescent probe for
detection and monitoring of C60 nanoparticles accumu-
lation in the cell. Shown in Fig. 2 are the confocal
fluorescence images of leukemic cells in dynamics of in-
cubation with C60-RITC. It can be seen that after 2 h of
incubation, the plasma membrane and the cytoplasm in
most of the cells in population appear stained. Intracel-
lular fluorescence intensity of C60-RITC was further
increased at 18 h indicating than no leakage of accumu-
lated nanostructure occurs. The data obtained confirm
that leukemic cells could effectively uptake fullerene C60
from the medium.
Our data are in agreement with studies where the up-
take of pristine C60 in nano-aggregated form by MCF10A
normal breast epithelial cells [16], lung epithelial adeno-
carcinoma A549 cells [28], and leukemic monocyte
macrophage RAW 264.7 cells [29] was demonstrated.
Taking into account that the dynamics of C60 uptake
by leukemic cells is delayed while simple diffuse through
the plasma membrane is a rapid process; it could be
postulated that C60 nanoparticles are taken up by slower
process of adsorptive endocytosis [5, 30]. In further
experiments, a 2-h incubation of cells with fullerene C60
was used.
Efficiency of fullerene C60 photoactivation largely de-
pends on the characteristics of the molecule optical ab-
sorption. In Fig. 3a, the spectrum of optical absorption of
fullerene C60 in water colloid suspension is shown. The
highest absorption is observed in the ultraviolet (265 nm,
345 nm) range; two peaks which are less in magnitude are
located in blue (450 nm) and red (600 nm) regions of the
visible light. UV waves are unfavorable in cancer ther-
apy because they do not possess the ability to penetrate
deeply into tissue and besides induce damaging effects.
Therefore, LED lamp with emission range in the visible
region of the spectrum of 410 –700 nm was used for
C60 photoexcitation. Emission spectrum of this lamp
showed the peak at 450 nm and extremum in the range
of 550–600 nm (Fig. 3b), which coincide with maxima
in absorption spectra of fullerene C60 in visible region.
Despite the common notion that photodamaging effect
of C60 on cancer cells is determined by effective produc-
tion of cytotoxic ROS in intracellular space [31, 32], the
biochemical pathways and signaling networks of its
realization still need to be elucidated.
Increased level of protein phosphorylation on tyrosine
residues caused by enhanced activity of phosphotyrosine
kinases (PTK) due to mutations, overexpression, and
autocrine-paracrine stimulation is one of the hallmarks
of uncontrolled cells proliferation and malignancy.
Application of drugs able to induce apoptosis by PTK
inactivation seems to be promising for antileukemic
therapy [33]. Protein tyrosine phosphorylation events
involved in signal transfer is shown to be regulated by
ROS, which could directly oxidize specific cysteine resi-
dues in protein tyrosine phosphatases or cross-talk indir-
ectly with upstream regulatory mechanisms. Taking into
account these facts, the comparative experimental study
of viability and protein phosphotyrosine (pTyr) status of
Jurkat cells treated with photoexcited fullerene C60,
staurosporine (a broad-acting protein kinases inhibitor),
or hydrogen peroxide (inducer of oxidative stress) was
done.
The data on viability of leukemic cells under used ex-
perimental conditions are presented in Fig. 4. It should
be noted that no statistically valid changes in viability
of leukemic cells subjected to irradiation with visible
light or fullerene C60 separately were detected (data not
shown). Only in the case of their combined action
Fig. 2 Confocal microscopy images (a) and fluorescence intensity (b) of Jurkat leukemic cells incubated with fullerene C60-RITC
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dose—dependent decrease of cell viability was detected
at 24 h. Approximately, 50% decrease of cell viability at
24 h was induced by comparatively equal concentra-
tions (about 50 μM) of both photoexcited C60 and
H2O2, while for STS, the index was much lower
(0.01 μM) (Fig. 4). In this connection, it must be noted
that cytotoxic effect of STS on normal cardiomyocytes
[34] and hepatocytes [35] appeared to be a limiting fac-
tor in STS application for anti-tumor therapy.
The next task was to estimate leukemic cell protein
phosphotyrosine status as the systemic marker of PTK-
dependent uncontrolled proliferation. The main immu-
noreactive bands detected by monoclonal antibodies
against phosphotyrosine correspond to proteins with
molecular weight in the range of 17, 26, 30, 50, 55, 70,
and 90 kDa (Fig. 5, track 1) confirming intense protein
tyrosine phosphorylation in leukemic cells. All investi-
gated agents induce decrease in protein phosphotyrosine
level in leukemic cells, but differences in intensity of de-
crease and in pattern of proteins with decreased pTyr
level were observed.
Treatment with STS was followed by total suppres-
sion of 30, 50, and 90 kDa protein phosphorylation,
trace-level phosphorylation of bands corresponding to
17, 55, and 70 kDa proteins was detected (Fig. 5, track
2). Treatment with H2O2 was followed by total dephos-
phorylation of 17, 30, 50, and 70 kDa proteins, as well
as reduced level of 55 and 90 kDa protein modification
(Fig. 5, track 3). Modification of 26 kDa protein in cells
exposed to STS appeared to remain at control level and
in cells treated with H2O2 to be even higher than in
control.
Combined action of fullerene C60 (50 μM) and visible
light was followed in general by less intensive decrease
of protein phosphotyrosine level in cells as compared
with that induced by STS or H2O2. The similar effects of
all tested agents (reduced phosphorylation of 55, 70, and
90 kDa proteins) were observed, while total suppression
of 26 kDa protein phosphorylation was specific only for
photoexcited C60. Based on the data obtained, we sug-
gest that 26 kDa protein could potentially participate in
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Fig. 4 Jurkat cell viability after treatment with STS (1—0.01 μM, 2—0.1 μM, 3—1 μM STS); H2O2 (1—25 μM, 2—50 μM, 3—100 μM H2O2);
photoexcited fullerene C60 (1—5 μM, 2—50 μM C60). *p < 0.05 in comparison to control
Fig. 3 Absorption spectra of fullerene C60 in water suspension (10
−4 M)
(a) and emission spectrum of light-emitting diode lamp (b) used for C60
photodynamic treatment of leukemic cells
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The data obtained show that inhibition of protein tyro-
sine phosphorylation could be involved into realization
of C60 photocytotoxic effects along with modification of
other signaling mechanisms and involvement of different
targets.
Considering the fact that the efficiency of anticancer
therapy is substantially limited by development of cancer
cells multidrug resistance, the photodynamic potential of
fullerene C60 was estimated in further experiments on
two leukemic cell lines—parental (L1210) and resistant
to cisplatin (L1210R). The data on cell survival after
treatment with 1 and 5 μg ml−1 of cisplatin as indicator
of drug sensitivity are presented in Fig. 6.
The viability of parental L1210 cells treated with
cisplatin was decreased in a dose and time-dependent
manner. At 24 h of incubation, the viability of L1210
cells treated with 1 μg ml−1 was decreased by 30% and
with 5 μg ml−1—by 50%, no cell survival was detected at
72-h incubation with 5 μg ml−1 of cisplatin (Fig. 6a).
Treatment of L1210 resistant cells with cisplatin in both
concentrations has no effect on cell viability. Minor de-
crease in viability of resistant cells treated with 5 μg ml−1
at 48 h was restored at 72 h (Fig. 6b).
No statistical decrease of L1210 or L1210R cell viabil-
ity at 24 and 48 h after treatment with C60 (50 μM) or
light irradiation per se was observed (Fig. 7). But after
combined treatment with fullerene C60 and light time-
dependent decrease of parental, L1210 cell viability (to
70 and 55% at 24 and 48 h, respectively) was observed
(Fig. 7a). It should be noted that phototoxic effect of
C60 was detected not only in parental but in cisplatin
resistant cells as well. At 48 h of incubation, the de-
crease of L1210R cell viability reached 50% (Fig. 7b)
that was similar to C60-mediated photodamaging effect
on parental leukemic cells.
Development of multidrug resistance (MDR) in cancer
cells is known to be accompanied by the overexpression
of ATP-binding cassette (ABC) transporters, which
provide efficient extrusion of drugs across plasma
membrane into extracellular space thereby decreasing
intracellular drug concentration [36]. The inhibitory ac-
tion of nanoparticles on ABC transporter activity due
to their direct or indirect interactions was suggested.
Efficient accumulation of pristine fullerene C60 in both
MDR and drug-sensitive human leukemia cells and in-
capability of P-gp type of ABC transporters to extrude
C60 nanoparticles was demonstrated in [37] as well as
our data confirm this suggestion. So, we assume that
phototoxic effect of fullerene C60 on cisplatin resistant
L1210 cells could be mediated by its efficient intracellu-
lar accumulation.
Fig. 5 Western blot analysis of protein phosphotyrosine level in
Jurkat cells at 24 h of incubation in control (1) and after treatment








































Fig. 6 Viability of L1210 (a) and L1210R (b) cells incubated in the
presence of cisplatin
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Evaluation of the early effects involved in activation of
death signaling pathways is a necessary step in determining
the mechanisms of photoexcited fullerene C60 long-term
cytotoxicity. Taking into account that mitochondrial trans-
membrane potential (Δψ) dissipation is an important early
marker of apoptotic cell death induction, we estimated the
relative value of mitochondrial membrane potential in
L1210 and L1210R cells at 3 h after photoexcitation of
accumulated fullerene C60.
The difference between relative values of mitochondrial
potential in parental and cisplatin-resistant leukemic cells
was demonstrated (Fig. 8). Intensity of TMRE signal in
L1210R was lower than that in L1210 cells. These results
are in agreement with data concerning decreased activity
of electron-transport chain and lower hyperpolarization of
mitochondrial inner membrane in drug-resistant cancer
cells compared to parental [38]. Leukemic cells resistant
to cisplatin are shown to express increased level of
uncoupling protein-2 (UCP2) and to maintain reduced
ΔΨ in comparison with cisplatin-sensitive cells, ensuring
by this way reduced ROS production and resistance to
cisplatin-induced apoptosis [39].
It was shown that irradiation in visible spectrum did
not change mitochondrial transmembrane potential in
cells of both lines (Fig. 8). After treatment with fuller-
ene C60, the relative value of mitochondrial membrane
potential in L1210 cells was decreased presumably due
to C60 interaction with mitochondrial membranes and
permeation into intermembrane space. It has been
proposed that the negative surface charge of hydrated
fullerene C60 clusters promotes binding to mitochon-
drial membranes with further dissipation of proton
gradient [40].
Combined treatment with fullerene C60 and irradiation
was followed by strongly pronounced decrease of TMRE
fluorescent signal not only in L1210 but also in L1210R
cells. The relative value of mitochondrial membrane
potential in L1210 and L1210R cells decreased by 2 and
1.6 times as compared with control values, respectively.
Considering the fact that our previous study has
demonstrated substantial increase of ROS production
in L1210 cells after pristine fullerene C60 photoexcita-
tion in UV/Vis spectrum [41], we suggested that C60


















































Fig. 7 Viability of L1210 (a) and L1210R (b) cells exposed to fullerene
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Fig. 8 Relative value of mitochondrial membrane potential in L1210 and L1210R cells exposed to fullerene C60, visible light irradiation, or their
combined action. *p < 0.05 in comparison to control
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generation after its photoexcitation are followed by
essential uncoupling of electron-transporting chain
components, proton leak across inner mitochondrial
membrane, and Δψ drop.
Summarizing, we assume that photoexcitation of accu-
mulated fullerene C60 with visible light could induce cell
death of parental and resistant to cisplatin leukemic cells
by ROS-dependent mitochondrial way.
Conclusions
In this study, stable homogenous water colloid solution of
pristine fullerene C60 was used in experiments for estima-
tion of C60 photocytotoxicity on leukemic cells. C60-RITC
conjugate was synthesized for monitoring C60 entry into
leukemic cells by confocal microscopy. Leukemic Jurkat
cells could uptake fullerene C60 from the medium and re-
tain the accumulated nanoparticles over 18 h. Combined
treatment with C60 and visible light is followed by time-
dependent decrease of Jurkat cell viability. Inhibition of
protein tyrosine phosphorylation could be one of the
mechanisms of C60 photocytotoxic effects realization.
C60-mediated photodynamic effect was demonstrated
also on leukemic L1210 cells both sensitive and resistant
to cisplatin. Decrease of drug-resistant cell viability after
C60 photoexcitation corresponded to a significant drop of
mitochondrial potential. The data obtained allow to sug-
gest that C60 photodynamic treatment might be a poten-
tial strategy for restoring the drug-resistant leukemic cell
sensitivity to induction of mitochondrial way of apoptosis.
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